Oncology Podcasts

Episode 2

Xofigo

Optimising patient identification and referral — Xofigo
®▼
(radium-223 dichloride)

Description

Hear from the perspective of both a leading oncologist and nuclear medicine consultant how they optimise the treatment and referral pathway for their patients.

Speakers:

  • Dr Julia Murray - Consultant Clinical Oncologist
  • Dr Amy Eccles - Consultant Radionuclide Radiologist and Clinical Lead

 

This promotional podcast series has been initiated and funded by Bayer and is for healthcare professionals only.

Speakers
    • Dr-Julia-MurrayDr Julia Murray

    Consultant clinical oncologist at The Royal Marsden NHS Foundation Trust and an honorary clinical senior lecturer at The Institute of Cancer Research, London, specialising in radiotherapy and systemic therapy for prostate cancer.

    Dr Murray graduated from Imperial College London in 2004 and undertook her general medical training in London. Her specialist clinical oncology training was completed at The Royal Marsden, Guy’s and St Thomas’ Hospital and St Luke’s Cancer Centre. In 2013, Dr Murray was awarded a Cancer Research UK PhD Fellowship at The Institute of Cancer Research and The Royal Marsden, evaluating image-guided prostate radiotherapy and the relationship between radiation dose and toxicity. She received her PhD in 2017 and was appointed as a consultant clinical oncologist in the urology unit at The Royal Marsden later that year. She is actively involved in clinical research of advanced radiotherapy technology to improve treatment accuracy and patient outcomes. She is also a trustee of the British Uro-oncology Group.

    • Dr-Amy-EcclesDr Amy Eccles

    Consultant Radionuclide Radiologist and Clinical Lead for Nuclear Medicine at Imperial College Healthcare NHS Trust, London.

    Dr Eccles has a specialist interest in nuclear medicine imaging and therapy, including hybrid and neuro-endocrine imaging (SPECT/PET-CT) for both oncology and musculoskeletal conditions.

Prostate cancer podcasts - The Xofigo (radium-223 dichloride) series
Episode 3
The Practicalities of Treatment — Xofigo®▼ (radium-223 dichloride)
PP-XOF-GB-0464, February 2024
Episode 1
Why treat with Xofigo®▼ (radium-223 dichloride)?
PP-XOF-GB-0462, February 2024

PP-XOF-GB-0463 | February 2024